~//bj.watch/overview
live

Latest signal

last curated pass Nov 4, 2026 · 8 public entries · source-aware summaries from 6 legacy curated cards plus llm-wiki tweets

# all # health # longevity # nutrition # sleep # concepts

Recent curated signals

Research claim “Closer to a cliff”: the menopause post’s “300M lab results” is real — 300 million tests across NHANES and Clalit in Nature Medicine, finding step-like jumps in 52/90 tests at the final menstrual period — but the study is three weeks old, retrospective, and its “cliff” framing is already publicly contested by menopause clinicians Johnson relayed a women’s-health claim: “Menopause was thought to be a gradual decline. This new study of 300M lab results suggests it may be closer to a cliff.” (426 likes, 14 reposts, 35 replies; November 4, 17:04 UTC, with an attached figure). The study verifies: Pridham, Hayut, Lavi-Shoseyov, Neeman, Hovav, Toledano, Alon, “Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period,” Nature Medicine, October 12, 2026 (10.1038/s41591-026-04614-0, open access) — the Weizmann/Clalit team applied an astronomy-inspired temporal deconvolution to two cohorts (NHANES 1999–2022 and Israel’s Clalit health insurer, 1.3 million female individuals aged 30–70) totaling 300 million laboratory tests, reconstructing final-menstrual-period-anchored trajectories from cross-sectional data. They found step-like jumps at the FMP in 52 of 90 US laboratory tests (jump sizes 0.1–1.4 s.d.) across endocrine, skeletal, hepatic, renal, inflammatory, and lipid systems; the jumps are absent in males, concordant across the two populations (r = 0.89), preceded by accelerated sex-hormone change ~12–15 years before the FMP (AMH ~15 years, FSH ~14, estradiol ~12 — about 7 years earlier than prior longitudinal work), and attenuated in self-reported menopausal-hormone-therapy users, especially bone, liver, and kidney measures. Boundaries: “300M lab results” is 300 million tests, not patients — the paper’s own abstract says “300 million laboratory tests”; the study is three weeks old and built on retrospective cross-sectional data with self-reported menopause status, its own named limitations; the MHT attenuation is associational, with healthy-user and access bias the authors say needs prospective randomized testing; and Australian menopause clinicians publicly pushed back within a day — Martha Hickey called the “cliff-like” framing “unnecessarily alarming” and noted “physiological cliff is not a scientific or medical term,” with the long-running SWAN cohort indicating a roughly three-year gradual transition; the post names no study. The dashboard records an attributed research relay with an exactly verified corpus — not a reader hormone-therapy decision, evidence about any individual’s menopause timing, or medical advice. Research claim “Zombie cells may have a kill switch”: the post describes a real one-day-old Cell paper — senescent cells run low on DGLA, and repleting it kills them by ferroptosis while healthy cells survive — a mouse-and-dish result with one associational human genetics leg, and Johnson’s own “would be interesting if replicated in humans” is the accurate boundary Johnson relayed a senescence claim: “Zombie cells may have a kill switch / As we age, some cells stop dividing but refuse to die. / They’re called “zombie” (senescent) cells. They pile up and inflame the tissue around them which is bad for you body. / This research group figured out how to kill them in mice. / They found that these zombie cells run low on one fatty acid: DGLA. So they added it back causing many of the zombie cells to die while the healthy cells survived. / They died by ferroptosis where the cell’s outer membrane oxidizes and breaks. / Would be interesting if replicated in humans.” (589 likes, 31 reposts, 47 replies; November 4, 17:46 UTC). The paper verifies: Kuehnemann, Jezak, Mogck, … Wiley, “Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis,” Cell (10.1016/j.cell.2026.09.036; Buck Institute-led with University of Eastern Finland and collaborators), announced November 3, 2026 — one day before the post. The mechanism is as posted: senescent cells show altered PUFA metabolism with selectively reduced dihomo-gamma-linolenic acid (DGLA, 20:3 ω-6); repleting DGLA (200 µM) — or inhibiting delta-5-desaturase (D5D/FADS1), the enzyme that metabolizes it — induces ferroptosis selectively in senescent cells across multiple induced-senescence models while healthy cells largely survive; oral DGLA ethyl ester (400 mg/kg, 5 consecutive days) lowered senescent-cell burden (p16 luminescence, SA-β-gal, SASP factors) and improved adipose, liver, and kidney markers in aged 22–24-month mice; and in the human Kuopio Obesity Surgery Study, a FADS1 variant that promotes DGLA accumulation was associated with lower adipose-tissue senescence markers. Boundaries: the intervention evidence is cell culture and aged mice — the liver clearance and functional gains are male-only in the paper and DGLA increased steatotic area, possibly to store the excess administered lipid; 400 mg/kg oral gavage in mice is a research dose with no established human equivalent; the human leg is a genetic association in bariatric-surgery patients, not an intervention trial; “kill switch” is Johnson’s gloss and the post names no study — but its own closing hedge (“would be interesting if replicated in humans”) is exactly right. The dashboard records an attributed research relay with a verified one-day-old paper — not evidence readers should supplement DGLA, a senolytic therapy, or medical advice. Measurement “Apparently my mitochondria are stressed by this”: the deadlift arithmetic checks (245→425 lb is +74%), but post-workout GDF15 rises are a normal exercise-stress response in healthy humans — the unpublished N=1 series rides a marker that moves with any vigorous workout Johnson posted a training-plus-biomarker disclosure: “I’ve been training really hard to dunk a basketball. / Deadlift up 74% (245 → 425 lb) / Apparently my mitochondria are stressed by this. / We’ve been measuring GDF15 after workouts and it rises and falls according to the difficulty level of the workout.” (516 likes, 8 reposts, 79 replies; November 4, 19:21 UTC, with an attached photo). The arithmetic checks — 245→425 lb is +73.5%, rounding to the posted 74% — and the number continues the tracked dunk-training storyline (October 25: 385 lb × 5 from the floor at an estimated ~445 lb 1RM, 2.47× bodyweight). The biomarker context verifies: Kleinert, Hempel, … Plomgaard, “Exercise increases circulating GDF15 in humans,” Molecular Metabolism 2018;9:187-191 (10.1016/j.molmet.2017.12.016 — seven healthy males, 60 min cycling at 67% VO2max, plasma GDF15 +34% at exercise end and +64% at 120-min recovery, rising in every subject with skeletal muscle not the source), and the response is intensity- and duration-dependent in trained adults (ACSM Medicine & Science in Sports & Exercise 2019, 10.1249/01.mss.0000561999.22383.5c). Boundaries: his own series is unpublished N=1 — no assay, values, timepoints, or dataset are published; because acute vigorous exercise raises GDF15 in healthy humans by itself, a post-workout rise is an expected physiological stress response, not evidence of mitochondrial damage, and “apparently my mitochondria are stressed by this” is his interpretation of a normal exercise-stress marker (one already tracked in the psilocybin-Parkinson’s relay, where GDF15 is framed as a mitochondrial-stress signal); GDF15 also moves with illness, inflammation, pregnancy, and weight change, so workout-difficulty correlation is not a validated training metric. The dashboard records an attributed N=1 measurement disclosure with verified context literature — not evidence that hard training harms mitochondria, a reader biomarker to track, or medical advice. Research claim “Walking to motivating music increased exercise by 15%”: the number is a real lab finding — treadmill time-to-exhaustion, up 15% under motivational synchronous music in the 2009 Brunel study — but the post drops the condition that made it work: stride-matched tempo Johnson relayed a music-exercise claim: “Walking to motivating music increased exercise by 15%” (1,593 likes, 62 reposts, 81 replies; November 4, 03:27 UTC, with an attached figure), quote-posting his own November 1 “listening to music while exercising is one of life’s greatest joys” post. The figure verifies: Karageorghis, Mouzourides, Priest, Sasso, Morrish, Walley, “Psychophysical and Ergogenic Effects of Synchronous Music during Treadmill Walking,” Journal of Sport and Exercise Psychology 2009;31(1):18-36 (10.1123/jsep.31.1.18; PubMed 19325186) — 30 university-age participants walked to exhaustion starting at 75% heart-rate reserve under motivational synchronous music, neutral (“oudeterous”) synchronous music, and no-music control; “the motivational music elicited a 15% increase in treadmill endurance over control and a 6% increase over oudeterous music,” with the music manipulation accounting for 38% of endurance-time variance. Boundaries: the 15% is laboratory time-to-exhaustion on a treadmill — endurance in a single session, not “exercise” as free-living physical-activity volume; the effect belongs to synchronous music, where stride rate is deliberately kept in time with musical tempo, a condition “walking to motivating music” quietly drops; N=30 young Brunel students walking near exhaustion, one 2009 study; motivational quality of the tracks was participant-selected; the post names no study. The dashboard records an attributed research relay with an exactly verified percentage — not evidence that background music raises daily activity, a reader walking protocol, or medical advice. Commercial “You can now eat the same foods as me”: Blueprint certifies a Tovala smart-oven meal line — Super Veggie and Nutty Pudding as subscription items — converting the weighed-gram protocol into a commercial food product Johnson announced the feed’s first meals-commerce launch: “You’ve all been asking for this. / You can now eat the same foods as me. / It’s easy and affordable. / > elite longevity ingredients / > freshly delivered / > in your own oven / > quick prep / > all food types / Feedback has been ⭐️⭐️⭐️⭐️⭐️” (425 likes, 14 reposts, 43 replies; November 4, 01:11 UTC, with an attached product photo). The launch verifies: Tovala announced “Longevity Meals,” a Blueprint-certified line built to the Blueprint protocol, on October 29, 2026 (PRNewswire) — weekly fresh delivery cooked by the Tovala Smart Oven via QR-code scan-to-cook cycles, Super Veggie and Nutty Pudding always on the menu alongside rotating chef-crafted dishes, developed with Chef Tara Amanya (Johnson’s personal chef and a Registered Dietitian Nutritionist), each meal “free from more than 100 banned ingredients” with no dairy, artificial preservatives, refined sugars, or hydrogenated oils, meals from $8.99 per serving with the oven from $69 (the Blueprint product page promoting it at $66.95 from $299), available across the continental U.S. Boundaries: this is a commercial milestone in the protocol-to-commerce pipeline the dashboard already tracks (the certified-brand marketplace, Immortals Rx, Immortals Concierge) — “elite longevity ingredients” is marketing language; the certification standard is Johnson’s own clinical team, so the certification is self-defined; no study shows that eating these meals improves any health outcome; and Tovala’s own FAQ restricts the protocol claim to meals carrying the Longevity tag. The dashboard records an attributed commercial launch with verified partnership facts — not nutrition efficacy evidence, a reader meal plan, or medical advice. Protocol guidance “most people sauna incorrectly”: the three-tier sauna protocol pairs real Kuopio cohort mortality and dementia findings with unpublished N=1 tiers — and a Level 3 whose own dose is stated twice, differently Johnson published the feed’s first tiered sauna protocol: “most people sauna incorrectly / > here’s three levels of sauna / > each triggers different benefits / > pick your fighter” — LEVEL 1: 11 minutes at 176°F (80°C) in a dry sauna (“your heart rate climbs… if you’re new, start here”; “Frequent sauna use is linked to a lower risk of cardiovascular death and lower overall mortality”); LEVEL 2: 20 minutes at 200°F (93°C) with his personal results (“10+ yr reduction in vascular age,” “87% less microplastics in blood,” “100% elimination of microplastics in semen”) and “Studies show 4-7 times/week at this level is linked to a reduction in mortality, heart disease, & dementia risk”; LEVEL 3: targeting a core body temperature of ~102.2°F (39°C), which he says he reaches at “31 minutes at 200°F (93°C),” tracked “via a pill I swallowed,” framed as the heat-shock-protein “deep repair tier” (2,316 likes, 86 reposts, 203 replies; November 3, 20:21 UTC). The population claims verify against the Finnish Kuopio cohort: Laukkanen et al., JAMA Internal Medicine, February 23, 2015 (10.1001/jamainternmed.2014.8187; 2,315 men aged 42–60, median 20.7-year follow-up) found 4–7 sessions/week vs once weekly at sudden-cardiac-death HR 0.37 (95% CI 0.18–0.75), fatal CVD HR 0.50, and all-cause mortality HR 0.60, with 11–19-minute sessions at sudden-cardiac-death HR 0.93 vs under 11 (duration effects significant for cardiac deaths but not all-cause mortality); and Kunutsor, Laukkanen, et al., Age and Ageing, March 2017 (10.1093/ageing.afw212) found dementia HR 0.34 and Alzheimer’s HR 0.35 at 4–7 sessions/week in the same 2,315-man cohort — so the mortality, heart-disease, and dementia legs are all real published associations, and the Level 1 11-minute figure is the 2015 paper’s own duration bin boundary. Boundaries: both studies are the same observational Finnish male cohort — self-selection (higher-risk men may avoid saunas, as the JAMA paper’s own published comment argues), a one-time baseline questionnaire, a mean sauna temperature of ~79°C that sits below the post’s 200°F/93°C Level 2, no randomization, and no women; the Level 2 personal results (vascular age, 87% blood-microplastics reduction, 100% semen elimination) are unpublished N=1 extending the tracked semen-microplastics storyline; the Level 3 heat-shock-protein tier generalizes his own single-participant HSP27 experiment and is internally inconsistent on its own dose — “31 minutes at 200°F” in the protocol line, “this took 33 minutes” two paragraphs later, against the 56 minutes the original June experiment reported; “most people sauna incorrectly” converts association into directive framing. The dashboard records an attributed protocol post with verified population literature and unpublished personal tiers — not a reader sauna prescription, evidence that heat doses extend life, or medical advice. Research claim “Medicine is a compute problem”: the figures verify almost exactly — Epic’s Cosmos holds 300M+ patients and 16.3B encounters, and its Curiosity models generate “the next medical event” — but the thesis line and “your next health event” are gloss the program does not support Johnson relayed a medical-AI claim: “Medicine is a compute problem. / This model was able to predict your next health event. / Trained on 300M patients and 16B health encounters. / We overestimate the mystery of our bodies and are more predictable than we want to believe. / Cool seeing that illusion chipped away.” (1,041 likes, 74 reposts, 68 replies; November 3, 23:47 UTC, with an attached figure). The quantitative signature verifies against Epic’s Cosmos/Curiosity program: Waxler, Blazek, et al., “Generative Medical Event Models Improve with Scale” (arXiv:2508.12104; Epic Systems with Microsoft Research and Yale School of Medicine), built on Epic Cosmos — “16.3 billion encounters over 300 million unique patient records from 310 health systems” — and introducing Curiosity, decoder-only transformers trained on a filtered subset of 118 million patients and 115 billion medical events (151 billion tokens) that “autoregressively predict the next medical event” to simulate patient health timelines, matching or outperforming task-specific supervised models on most of 78 evaluation tasks; Epic announced Curiosity in September 2025 and said at its August 2026 user meeting that it will ship inside the EHR in March 2027, with Cosmos by then above 320 million patients. Boundaries: “Medicine is a compute problem” and the “mystery of our bodies” line are Johnson’s gloss — the paper is sequence modeling over billing-grade EHR events, not understanding of bodies; “your next health event” overstates access — Curiosity is available to Cosmos-contributing health systems for research and workflow use, not to individuals; the models inherit the real-world-data limits the paper itself lists (documentation error, care delivered outside Epic leaving record gaps, discretized lab values, an 8,192-token context window shorter than many full histories, and no prospective validation); predictions are probabilistic trajectories, not diagnoses; and the post names no model, paper, or vendor. The dashboard records an attributed AI relay with an exactly matched training corpus — not a diagnostic service available to readers, evidence that individual health is fully predictable, or medical advice. Research claim “Music is a longevity therapy”: the trial count verifies exactly — 104 RCTs and 9,617 participants — and all four claimed benefits are real measured outcomes, but the meta-analysis behind them measures stress reduction, not longevity Johnson closed a same-day music thread with the feed’s first music-as-therapy claim: “Music is a longevity therapy / > lowers heart rate / > lowers blood pressure / > lowers cortisol / > lowers anxiety and restlessness / Protocol: a song you love. / 104 randomized trials / 9,617 people” (2,099 likes, 149 reposts, 126 replies; November 1, 18:36 UTC, with an attached figure). The post’s quantitative signature verifies exactly: de Witte, Spruit, van Hooren, Moonen, Stams, “Effects of music interventions on stress-related outcomes: a systematic review and two meta-analyses,” Health Psychology Review, June 2020;14(2):294-324 (10.1080/17437199.2019.1627897; PubMed 31167611), two multilevel meta-analyses of exactly 104 RCTs with exactly 9,617 participants (327 effect sizes) — and each of the four claimed benefits maps onto a measured outcome: heart rate (d = .456), stress-related hormone levels including cortisol (d = .349), blood pressure (d = .343), and anxiety/restlessness-type psychological outcomes (d = .545), with overall physiological d = .380 and psychological d = .545. The boundary the post drops is the title: the paper measures stress reduction, not longevity — no included trial tracked mortality, disease, or aging endpoints, so “longevity therapy” is gloss the paper does not make. Additional boundaries: the pooled effects are small-to-medium (d = .34–.55) and heterogeneous across settings; the paper’s own limitation is a mostly short-term, often single-session evidence base, leaving long-term effects largely unexamined; “lowers cortisol” narrows the paper’s broader “stress-related hormone levels” outcome class; the post names no study; and the claim arrived at the end of a thread primed by a 4,492-like joy post and a 668-like engagement question (583 replies). The dashboard records an attributed research relay with an exactly verified trial count, real outcome directions, and a category upgrade the paper does not support — not evidence that listening to music extends life, a reader listening protocol, or medical advice.

// Reference paths

Move from feed to dossiers

Each route keeps source trails and medical caution visible.
Protocol Health

Habits, Longterm, and Don’ts for measurement loops, sleep consistency, oral care, exercise, and experimental-intervention caution.

 Protocol Longevity

Habits, Longterm, and Don’ts for biomarkers, healthspan basics, critiques, and low-confidence immortality claims.

 Protocol Nutrition

Habits, Longterm, and Don’ts for plant-led meals, Blueprint products, microplastics claims, and metabolic-drug caveats.

 Protocol Sleep

Habits, Longterm, and Don’ts for bedtime discipline, front-loading examples, and metric caution from tweet-backed sources.

 Reference Concepts

39 source-aware glossary entries, including concepts without dedicated wiki pages yet.

 entity Blueprint

Blueprint is bryan-johnson's longevity protocol, product company, and public measurement system. It began as Project Blueprint, an N=1 effort to measure Johnson's organs and biological aging, and later became a consumer

 concept Blueprint Protocol

The Blueprint Protocol is bryan-johnson's closed-loop health system: measure body state, consult scientific evidence, implement interventions, measure again, and update. Johnson treats the body as a system whose organs a

 concept Don't Die

Don't Die is bryan-johnson's community slogan, longevity philosophy, and civilizational frame. The official Don't Die page describes a community “united in defeating all causes of human and planetary death and building a

 concept Biomarker-driven longevity protocols

A biomarker-driven longevity protocol is a health system that treats the body as a measurable control system: collect biomarkers, choose interventions, re-measure, and iterate. project-blueprint is the most visible curre

 Signal Metrics

Inspect source velocity by range, content type, and fallback API state.